Drug Profile
Research programme: calcium channel modulators - Grunenthal
Alternative Names: Cav2.2 modulators - Grunenthal; Pain – Cav2.2 - GrunenthalLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Grunenthal
- Class Analgesics
- Mechanism of Action Calcium channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in Germany
- 19 Apr 2013 Early research in Pain in Germany (unspecified route)